ストックスクリーナーアプリを入手
98.89
4.69%
-4.70
Grail Inc (GRAL) 最新ニュース
Morgan Stanley eyes emerging growth for Grail (GRAL) as sector valuations reach equilibrium - MSN
GRAIL (GRAL) Is Up 12.3% After Samsung-Backed Asian Galleri Deal And Trial DataHas The Bull Case Changed? - simplywall.st
GRAIL, Inc. (GRAL) Stock Analysis: Eyeing a 9.66% Upside with Innovative Cancer Detection - DirectorsTalk Interviews
Why Illumina (ILMN) Is Up 6.5% After Advancing Grail Divestiture Plan And What's Next - Yahoo Finance
Avoiding Lag: Real-Time Signals in (GRAL) Movement - Stock Traders Daily
Should Illumina’s (ILMN) Grail Spinoff to Ease Regulatory Pressure Require Action From Investors? - simplywall.st
Assessing GRAIL (GRAL) Valuation After Pathfinder 2 Success and Samsung’s Asian Galleri Deal - simplywall.st
Small-Cap Standouts: These 3 Stocks Rose Over 300% in 2025 - Finviz
Grail Inc (GRAL) Climbs 380% on Strong Optimism for Cancer Detection Kit - Insider Monkey
GRAIL Earnings Notes - Trefis
Samsung and GRAIL Announce Strategic Collaboration To Bring GRAIL’s Galleri® Multi-Cancer Early Detection Test to Asia - samsung.com
GRAIL stock drops in New York session as Galleri FDA filing timeline returns to focus - ts2.tech
Legal Advantage Investments Inc. Invests $1.24 Million in GRAIL, Inc. $GRAL - MarketBeat
Early Cancer Detection Firm Grail Leads Nasdaq Gainers as Stock Jumps 20% - MSN
Morgan Stanley Eyes Emerging Growth for Grail (GRAL) as Sector Valuations Reach Equilibrium - Insider Monkey
GRAIL: Making Strides In Cancer Detection (NASDAQ:GRAL) - Seeking Alpha
Carnegie Investment Counsel Increases Stake in GRAIL, Inc. $GRAL - MarketBeat
Blood test finds seven times more cancers than standard screenings - OHSU News
(GRAL) Risk Channels and Responsive Allocation - Stock Traders Daily
Archaeopteryx | The Holy Grail of Fossils at the Field Museum - Britannica
Sheets Smith Investment Management Takes $1.69 Million Position in GRAIL, Inc. $GRAL - MarketBeat
GRAL Stock: Cancer Detection Firm Targets Further Upside After 381% Rally - CMC Markets
Why Fusion Is Considered Energy’s Elusive Holy Grail - The Wall Street Journal
Westwood Holdings Group Inc. Has $899,000 Holdings in GRAIL, Inc. $GRAL - MarketBeat
How Recent Catalysts Are Shifting the Narrative for GRAIL - Yahoo Finance
GRAIL to Present at the 44th Annual J.P. Morgan Healthcare Conference - The AI Journal
NWF Advisory Services Inc. Makes New $1.06 Million Investment in GRAIL, Inc. $GRAL - MarketBeat
64,560 Shares in GRAIL, Inc. $GRAL Bought by Caxton Associates LLP - MarketBeat
Trading the Move, Not the Narrative: (GRAL) Edition - news.stocktradersdaily.com
Here's Why Grail Soared, Again, in November - AOL.com
BBR Partners LLC Sells 35,000 Shares of GRAIL, Inc. $GRAL - MarketBeat
GRAIL (GRAL) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
GRAIL : Non-Invasive Urinary Detection of Upper Tract Urothelial Carcinoma via Methylation Patterns in Cell-Free DNA View Presentation - marketscreener.com
Rhumbline Advisers Has $2.54 Million Holdings in GRAIL, Inc. $GRAL - MarketBeat
Jim Cramer Says “Salesforce Now Has The Holy Grail” - Yahoo Finance
Insider Sell: Joshua Ofman Sells 13,000 Shares of GRAIL Inc (GRA - GuruFocus
GRAIL (GRAL) Price Target Increased by 16.67% to 107.10 - Nasdaq
Grail Insider Sold Shares Worth $2,478,818, According to a Recent SEC Filing - marketscreener.com
Grail Insider Sold Shares Worth $3,809,535, According to a Recent SEC Filing - marketscreener.com
Will GRAIL Inc. (NL0) stock draw ESG focused fundsQuarterly Trade Review & Long-Term Growth Portfolio Plans - Newser
Here's Why Grail Stock Exploded Higher by 55% in October - AOL.com
Will GRAIL Inc. (NL0) stock attract long term capital inflows2025 Macro Impact & AI Forecasted Stock Moves - Newser
CFO Freidin Files To Sell 25,000 Of Grail Inc [GRAL] - TradingView
Grail: Downgraded From Speculative Buy To Hold As The Stock Price Appreciated Faster Than Expected - Seeking Alpha
(GRAL) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
Creative Planning Takes $725,000 Position in GRAIL, Inc. $GRAL - MarketBeat
GRAIL (NASDAQ:GRAL) Stock Price Down 6.7%What's Next? - MarketBeat
GRAL: Morgan Stanley Raises Price Target to $110, Maintains Equa - GuruFocus
Is GRAIL Inc. (NL0) stock undervalued historically2025 Technical Overview & Free Risk Controlled Daily Trade Plans - Newser
How GRAIL Inc. (NL0) stock responds to job market shifts2025 Price Action Summary & Intraday High Probability Setup Alerts - Newser
Will GRAIL Inc. (NL0) stock benefit from mergersMarket Sentiment Review & Free Safe Capital Growth Stock Tips - Newser
Morgan Stanley Raises Price Target on GRAIL to $110 From $85, Keeps Equalweight Rating - marketscreener.com
Cancer-Detecting Blood Tests Are on the Rise. Do They Work? - The New York Times
0.75%
2.16%
大文字化:
|
ボリューム (24 時間):